New methods applied to the analysis and treatment of ovarian cancer.
D000951:Antigens, Neoplasm; D002272:Carcinoembryonic Antigen / Q000032:analysis; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007106:Immune Sera; D008297:Male; D008558:Melphalan / Q000627:therapeutic use; D009367:Neoplasm Staging; D010051:Ovarian Neoplasms / Q000175:diagnosis* / Q000401:mortality / Q000628:therapy*; D010534:Peritoneal Neoplasms / Q000556:secondary; D010761:Phosphorus Radioisotopes / Q000627:therapeutic use; D011879:Radiotherapy Dosage
D000951:Antigens, Neoplasm; D002272:Carcinoembryonic Antigen; D007106:Immune Sera; D010761:Phosphorus Radioisotopes; D008558:Melphalan